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Summary.-The successful development of the concept of linking cell-killing agents
to tumour-specific antibodies will be largely determined by the extent to which the
antibodies are preferentially localized in the malignant tissue. A xenograft of human
choriocarcinoma (CC3) has been established in nude mice, and the relative distribu-
tion of affinity-purified specific antibodies to human chorionic gonadotrophin has
been compared with that of nonspecific antibodies from the same species. Treatment
of the nonspecific antibodies with ammonium thiocyanate appeared to be important
to ensure that the distributions in normal nude mice were equivalent. Specificity
indices, derived from the comparative distributions of isotope activity in the tumour
and lung of labelled specific and nonspecific antibodies, ranged between 1-3 and 2 0.
THERE HAS RECENTLY BEEN renewed
interest in the use of antibodies as carriers
for diagnostic agents and anti-tumour
agents. A primary consideration is the
extent to which the antibodies are retained
in the malignant tissue, compared with
their concentration in other, non-target
tissues and body fluids. If a specific
concentration ofantibody can be achieved
in the target tissue, further studies are
neededtodeterminewhethertheantibodies
are internalized into the malignant cell or
retained at or near the cell surface since
this would influence the nature of the
conjugates required for chemotherapy.
Antibodies may be directed at secreted
tumour products as well as at membrane-
bound antigens.
Investigations of human colonic-cancer
xenografts in hamsters have shown that
3-40 of an injected radioactive dose of
iodinated, affinity-purified, specific anti-
body to carcinoembryonic antigen (CEA)
remained per gram oftumour after 8 days.
Nonspecific labelled antibody cleared more
rapidly from the tumour, giving a specific:
nonspecific ratio of 7.72 + 1.47 (Primus
et al., 1.977). In nude mice carrying human
10
colonic-cancer xenografts, optimal visual
contrast between the tumour and normal
tissue was seen at Day 3 by scanning
animals given 2 jig of radio-labelled anti-
CEA antibodies diluted with 200 ug of
normal goat y-globulins (7S fractions of
both). Localization ratios of 4.5:1 were
obtained (Mach et al., 1974). It has been
clearly shown by postoperative investiga-
tions in humans that antiCEA antibodies,
whether intact or as fragments, can local-
ize preferentially in tumour tissue as
compared to normal tissues (Mach et al.,
1980) but the actual recovery of antibody
from the tissue is disappointingly small.
After 6 days it is about one-thousandth
of the administered dose, assuming that
the radioisotope remains largely associated
with the protein.
Another model to study the localization
of antibodies is provided by the human
choriocarcinoma xenograft. Antisera to
human chorionic gonadotrophin (hCG)
have been well characterized (Bagshawe
et al., 1979). Hertz (1959) reported the
successful growth of metastatic chorio-
carcinoma (Strains BO, MA and WO in
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and in conditioned rats. Further lines were
established in hamsters (Ehrmann &
Glisermann, 1964; Galton et al., 1963;
Hertz, 1967) while Lewis reported the
heterotransplantation of choriocarcinoma
in the monkey (Lewis et al., 1968). Serial
transplantation ofan hCG-producing testi-
cular tumour into immune-deprived mice
produced a xenograft (HX36) which
retained characteristics of the original
tumour, but there was a loss in hCG-
producing cells after prolonged passage
(Selby et al., 1979).
The relative distribution of anti-hCG
y-globulins and non-immune y-globulins
in Syrian hamsters carrying cheek-pouch
tumours of human gestational chorio-
carcinoma has been compared by total-
body scans (Quinones et al., 1971). Unfor-
tunately, in the ammonium sulphate-
derived fractions of antisera used by these
authors for double isotope experiments,
nonspecific immunoglobulin in the specific
antiserum would have been labelled in-
appropriately. Also the expression of
results as tissue/blood ratios may depend
heavily on the differential clearance of
free and complexed circulating anti-
bodies.
The nude mouse has been shown to be a
suitable host for human choriocarcinoma,
morphological and biological characteris-
tics of the tumour being maintained over
serial passages (Kameya et al., 1976). In
the present paper we report studies on a
xenograftofhumanchoriocarcinoma which
has been established in nude mice. Pre-
liminary studies were undertaken to show
that specific and nonspecific antibodies
could be paired to ensure that they be-
haved identically in non-tumour-bearing
nude mice. The distribution of these anti-
bodies in animals carrying the xenograft
was then studied.
METHODS AND) RESULTS
The CC3 xenograft
A fresh surgical specimen of human
uterine choriocarcinoma was diced into
- 2mm3 fragments and washed twice in
culture medium containing penicillin and
streptomycin (Wellcome Reagents, TC199
Single strength). One fragment was im-
planted s.c. into 2 male and 4 female nude
mice, 10 weeks old, at each of 2 sites.
Tumours developed in the anterior site
(left flank, level with last rib) in all animals
after 10-32 days. Tumours developed in
the posterior site (over the sacrum) in the
female animals only. (It has been sugges-
ted previously that regional differences
exist in the incidence of successful xeno-
graft growth in nude mice (Auerbach et al.,
1978).) The tumour has been passaged 6
times, remaining morphologically stable
(Figs. 1 & 2). The CC3 tumour grows as a
non-invasive encapsulated nodule in the
s.c. space and does not appear to metasta-
size. Histologically it can be classified as a
poorly differentiated choriocarcinoma con-
taining both cytotrophoblastic and syn-
** * * w ** . * *s w **2;:.
FIG. 1. CC3 choriocarcinoma xenograft
showing central necrosis. A narrow fibrous
layer surrounds and subdivides the tumoui,
and a chronic inflammatory infiltrate can
be seen in the surrounding connective
tissue. H&E x 95.
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Fia. 2. CC3 choriocarcinoma xenograft
showing marked cellular and nuclear
pleomorphism. Indistinct cell boundaries
and multinucleated cells can be seen, but
no unequivocal syncytiotrophoblast. H&E
x 450.
cytiotrophoblastic elements. However, un-
equivocal syncytiotrophoblast cannot be
seen in all sections. The tumour cells
show marked cellular and nuclear pleo-
morphism(Figs. 1 & 2).Largehaemorrhagic
spaces are seen, and extensive central
necrosis is a common feature ofthis model
(and is maintained over serial passage).
The latent period before tumour was de-
tectable was extremely variable initially,
but is now 20-40 days. The histology of
the original tumour is included for com-
parison (Figs. 3 & 4).
Measurement of hCG in mouse serum
Weekly serum-hCG- values were meas-
ured for 10 animals implanted with
tumour material of the third passage and
10 sham-operated controls, using an
automated f-subunit-directed assay (Kar-
~.
FIG. 3. Human uterine choriocarcinoma
from which the CC3 xenograft was derived.
H&E x 95.
dana & Bagshawe, 1976). Standards were
made up in normal human serum, mouse
sera being diluted 1: 4 in normal human
serum. The values obtained were plotted
against estimates of tumour volume cal-
culated by the formula vol. = IL x W x H,
where L, W and H are the perpendicular
diameters of the tumour (Looney et al.,
1973).
In individual tumour-bearing animals,
the rate of change of serum hCG closely
paralleled the rate of change of estimated
tumour volume; a typical result is shown
in Fig. 5. No detectable serum hCG was
noted in controls up to 7 weeks after sham
operation. Absolute serum-hCG values
were not found to be a reliable indicator
of tumour volume when comparing dif-
ferent animals, possibly reflecting variable
proportions of viable and necrotic tissue.
Typical gonadotrophic responses to cir-
culating hCG can be seen in host mice, in
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FIG. 4. Human uterine choriocarcinoma
from which the CC3 xenograft was derived.
H&E x 450.
particular ovarian follicular stimulation
and haemorrhage and ovarian hyperaemia.
Distribution of thiocyanate-treated non-
immune rabbit y-globulin and anti-hCG
rabbit y-globulin in normal male nude mice
Normal rabbit y-globulin (Nordic, rab-
bit IgG, Batch 27-479) (1 mg/ml) was
treated with 2-5M ammonium thiocyanate
in phosphate buffer (0-05M, pH 7.5) for
1.5 h at 4°C, and dialysed thoroughly
against phosphate buffer at 4°C. The
resulting y-globulin preparation was label-
led to a sp. act. of 1.5 ,uCi/,tg with 1251
(IMS 30, Amersham) in ice, by a modifica-
tion ofthe chloramine-T method (McCona-
hey & Dixon, 1969). The combined peak
protein-containing fractions from frac-
tionation on Sephadex G-200 (column
dimensions 1-5 x 30 cm) were diluted in
saline, and 100 pl injected by tail vein into
6 normal nude mice, so that each received
3 HCi 1251/2 ,tg y-globulin.
Specific anti-hCG rabbit y-globulins
(Begent et al., 1980) were purified by
affinity chromatography against an hCG-
immunoabsorbent (Sepharose 4B-CNBR-
hCG). The columnwas prepared bybinding
327 mg hCG, (Sigma, bioassay 2570 i.u./
mg; radioimmunoassay 1 mg/ml= 1400
i.u./ml), to 30 g of gel. The y-globulins
were eluted with 2-5M ammonium thio-
cyanate through Sephadex G.25 and then
dialysed against phosphate buffer (0.05M,
pH 7.5) and labelled with 1311 (IBS 30,
Amersham) to sp. act. 1 ,uCi/pg. The
corresponding combined peak protein
fractions from the G-200 Sephadex column
were diluted in saline, and lOO,ul volumes
injected into the same 6 mice immediately,
so that each mouse received 2 juCi 1311/
2 ,tg y-globulin.
After 3 days the mice were killed and
the organs were excised and the weighed
tissues were counted for 1311 and 1251
(LKB-Wallac 8000, 60 sec). The "total
injected" was also counted on the day of
excision by means of reference aliquots.
Surface blood was removed from tissue
samples by careful blotting. The results
are given in Table I. The immunological
activity of the 1311-labelled antibody was
checked relative to the starting material
by an antiserum dilution curve with
1251-labelled hCG. 60-70% of the binding
activity was consistently maintained.
Comparison of the distribution of non-
imm,une rabbit y-globulin and anti-hCG
rabbit y-globulin in nude mice bearing
human choriocarcinoma xenografts
The paired antibodies which had been
shown in the previous experiment to be
distributed equally in normal nude mice
were labelled and injected as before
(1251-normal y-globulin, 3 MCi/2 ,ug;
1311-anti-hCG y-globulin 2 ,Ci/2 jug per
animal) into 5 male nude mice bearing
CC3 xenografts of the 6th passage. The
mice were killed after 5 days and the
tumours and organs excised and counted
as for the normal animals. The results are
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TABLE I.-Localization of 131I-labelled antibody to hCG and 125I-labelled non-immune
rabbit IJG in tissues of normal mice
Organ
Blood
Liver
Kidney
Lung
Spleen
Colon
Muscle
131I
(ct/min/g)
128841
29486
33268
48932
42306
17188
9687
Mean +s.d. for 6 animals
Blood
Liver
Kidney
Lung
Spleen
Colon
Muscle
* % T =ct/min/g as of total injected.
shown in Table II and specificity indices,
calculated according to the formula:
Tumour ct/min/g as % of total/lung
ct/min/g as % total, for specific antibody
Tumour ct/min/g as % of total/lung
ct/min/g as % total, for nonspecific
antibody
are given in Table III.
DISCUSSION
It can be seen by comparing Figs 1
and 2 with 3 and 4 that the consistent
histological appearance of the human
choriocarcinoma cells (CC3) has been
maintained during their passage in nude
mice. Thus the first essential requirement
of our xenograft model has been fulfilled.
That the functional integrity ofthe cells is
sustained is evidenced by the steady
release of hCG into the mouse serum (Fig.
5). The high levels of hCG in the serum
simulate the clinical situation. Under
these circumstances, circulating complexes
between hCG and xenogeneic antibodies
have been indicated (Begent et al., 1980).
We have established (Table I) that, if
the antibodies are paired carefully, both
the specific and nonspecific Y-globulins are
distributed equally in the tissues ofnormal
nude mice. For 6 normal animals, the
mean+s.d. of the counts per gram as a
percentage of the total injected were
calculated for each tissue listed, and the
linear regression plotted (n=7, r=0*998
and 0-925, respectively, P< 0.001) for
the specific and nonspecific antibodies.
Treatment of the control y-globulin
with ammonium thiocyanate (as in the
elution of affinity-purified specific y-
globulins) appeared to be an important
1 - 3lDC
FIG. 5. Circulating levels of human chori-
onic gonadotrophin in the serum of a nude
mouse during the growth of the CC3 xeno-
graft. , hCG; - tumour volume.
Ratio
1-00
0 23
0-26
0-38
0 33
0-13
0-08
% T*
1-08
0-24
0-27
0-41
0 35
0-14
0-08
125I
(ct/min/g)
249858
57034
65632
98868
80739
34345
20146
Ratio
1-00
0-23
0-26
040
0-32
0-14
0-08
0-92+ 0-10
0-16 + 005
0-23 + 0-03
039 + 0.05
0-33 + 0-02
0-13 + 0-03
0-08 + 0-02
% T
0.99
0-22
0-26
0 39
0-32
0-13
0-08
0-81 + 0-10
0-14+ 0-04
0-21+ 0 04
0-36 + 0 04
0-26+0-04
0-11+0-02
007 + 003
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TABLE II. As Table I, for mice bearing hunman choriocarcinoma xenografts
1311
Organ (ct/min/g) Ratio
Blood 81591 1-00
Liver 20589 0 25
Kidney 17607 0-22
Lung 33299 0-41
Spleen 20732 0-25
Colon 8895 '011
Muscle 8007 0 09
Tumour
(0-686 g) 19428 0-24
Fluid
(0-1110g) 77695 0.95
2 Blood 169730 1-00
Liver 44530 0 26
Kidney 44085 0 26
Lung 71157 0-42
Spleen 51982 0-31
Colon 21073 0-12
Muscle 14496 0-08
Tumour
(0-156 g) 251054 1-48
Necrotic
(0-061 g) 117832 0-69
3 Blood 140117 1-00
Liver 29729 0-21
Kidney 45145 0-32
Lung 62842 0 45
Spleen 30877 0-22
Colon 15545 0-11
Muscle 13879 0-10
Tumour
(0-151 g) 273010 1-95
Necrotic
(0-240 g) 165455 1-18
4 Blood 174846 1-00
Liver 56893 0 33
Kidney 54587 0-31
Lung 87101 050
Spleen 57299 0 33
Colon 26373 0-15
Muscle 18422 0-11
Tumour
(0-143 g) 216464 1-24
Necrotic
(0-296g) 138299 0 79
5 Blood 87317 1-00
Liver 24251 0 28
Kidnev 15594 0-18
Lung 39239 0 45
Spleen 33486 0-38
Colon 8439 0-10
Muscle 11575 0-13
Tumour
(2-203 g) 64632 0-74
% T
0-31
0-07
0-06
0-12
0-07
0 03
0 03
0-07
0-29
0-64
0-17
0-16
0-27
0-19
0-08
0*05
0 95
0 45
0 53
0-11
0-17
0-24
0-11
0*05
0*05
1-04
0-63
0-66
0-21
0-20
0 33
0-21
0-10
0-07
0-82
0-52
0 33
0 09
0*05
0-14
0-12
0-03
0 04
0-24
125I
corrected
(ct/min/g) Ratio
255357 1-00
65934 0-26
63626 0-25
123953 0 49
60006 0-24
34724 0 14
32619 C iO
40559 0-16
227340 0-89
354336 1-00
90036 0-25
100889 0-28
163351 0-46
99619 0-28
46237 0-13
33725 0-10
332595 0-91
207884 0-57
297929 1 00
65787 0-22
103177 0 35
147842 0 50
68759 0-23
40046 0-13
32766 0-10
320006 1-07
280190 0 94
374527 1-00
117961 0-31
128137 0 34
201145 0 54
117998 0-32
63985 0-17
41869 0-11
372795 1-00
242122 0-65
268085 1-00
68059 0-25
53278 0-20
141965 0-53
91719 0 34
44948 0-17
41623 0-16
167101 0-62
factor in matching the biological half-life paired for molecular size by G-200
of the antibodies. The evidence for the chromatography. The isotope labels could
effect ofthiocyanate on the distribution of be reversed without altering the distribu-
y-globulins in normal nude mice will be tion in normal animals. It can therefore
presented separately (Lewis & Keep, in be presumed that any difference in distri-
preparation). The 2 antibodies were bution encountered in tumour-bearing
142
% T
2 21
0 57
0*55
1-07
0-52
0 30
0-28
0 35
1-97
3 07
0-78
0-87
0-41
0-86
0 40
0-29
2-79
1-80
2-58
0-57
0-89
1-28
0.59
0 34
0-28
2-77
2-42
3-24
1-02
1-11
1-74
1 02
0*55
0-36
3-23
2-10
2-32
0 59
0-46
1-20
0 70
0-31
0-36
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TABLE III. Specificity indices for anti-
hCG labelling in tumour-bearing mice,
calculated from, data of Table II
AlMouse
1)
3
4
5
Tumour/
lung
1-80
1-70
2-00
1-36
1-46
Tumour/
liver
1-67
4-72
1 97
1-21
*1 3
Tumour/
muscle
1-84
1-98
2-10
1 -31
1-54
animals is determined by the antigenic
specificity of the immune antibody,
whether by direct binding of the free
antibody or as a function of complex
formation with antigen in body fluids.
The expression of the results must
attempt to take into account 2 factors:
circulating complexes may change the
overall pattern of distribution of the
isotope associated with the specific anti-
body; and genuine preferential retention
may occur in the tumour as a result of
antigen-antibody binding in situ.
We have obtained specificity indices
based on the ratio of the counts retained
in the tumour to those in the lung, liver
and muscle (Table III). In each
xenografted animal the lung was the
normal organ with the highest associated
counts. Since this tissue contains a rela-
tively higher level of blood contamination
(J. C. M. Lewis, unpublished) and of
macrophages, it seems reasonable to
suggest that if specificity indices are
demonstrated to be greater than unity
when compared to the lung control, there
is preferential retention in the tumour.
Specificity indices of 1*36 to 2.0 were
found relative to the lung (Table III).
Despite the fact that antibodies were
paired so that they behaved identically
in normal nude mice, the overall clearance
rate of the nonspecific antibodies in the
tumour-bearing mice appeared to be
diminished. This is most clearly seen in the
histograms (Fig. 6) which are a graphical
representation of results for 2 mice from
Tables I and II. Further work, with con-
trols deliberately injected with varying
levels of circulating hCG, may clarify
whether it is the presence of circulating
immune complexes, or ofthe tumour itself,
which is responsible for the depressed
clearance rate of the nonspecific antibody.
It is evident that the exact tumour
localization ratio can vary depending
upon the time at which tissues are excised.
It seems probable that an observed
differential distribution between specific
and nonspecific antibodies is determined
largely by the time taken for the specific
antibody or its complex to be leached
away from the neighbourhood ofthe malig-
nant tissue, i.e. retention rather than
uptake is the dominant factor. The diffu-
sion of specific antibodies towards the
tumour may be severely hampered by
complex formation with circulating anti-
gen. It is interesting that, as in the
example quoted in Table II, the cyst
fluid retains a relatively high level of
Normal mouse (3 days)
3
2
1
'a
0
0
0
o
en
2
-
0
I
* specific antibody-I 131
non-specific antibody-1125
Tumour-bearing mouse (2) (5 days)
I
I I
I I I~h.p h. , , I I I I I
C: ,l, c c c, : E°
Fie',. 6. The distribution of isotopically
labelled anti-hCG y-globulins (1311) and
non-immune y-globulins (1251) in normal
and CCM3-tumour-bearing nude mice.
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antibody. This would be consistent with
the observation (Selby et al., 1979) of
high hCG levels in fluids from the centre
of the xenografted tumouur HX36. Trap-
ping of immune complexes may be occur-
ring in our model. The relative mobility
of antibodies into and from cystic spaces
with poor surrounding vasculature may
contribute to apparent localization, even
though the specific antibody or complex
is not in intimate contact with the malig-
nant-cell surface. There are obviously a
number of questions still to be answered
regarding the fate of the antibodies. We
hope to determine by autoradiography
what proportion of the antibody is inter-
nalized by the malignant cell.
During the radioimmunodetection of
hCG-producing cancers in humans, acti-
vity-concentration ratios ofiodine-labelled
anti-hCG varying between 1 and 2.87
have been found (Goldenberg et al., 1980).
It appears reasonable to suggest that the
CC3 choriocarcinoma xenograft, with
specificity indices of 1-4 to 2.0, is a realistic
working model for considering further the
specificity and efficacy of drug-linked
antibodies.
We are grateful for the support of the Medical
Research Council and the Cancer Research Cam-
paign.
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